Among People Who Inject Drugs, A Low-Barrier HepC Treatment Model Is Linked To Higher Cure Rates

A low-barrier treatment entry model for hepatitis C (HCV) was linked to higher rates of cure among adults age 18 and older who injected illicit drugs. The model co-located a hepatitis treatment professional and a Hepatitis C Care Coordinator (HCCC) on-site at a collaborating needle exchange program. Outcomes of the low-barrier model were compared to the usual process of referring consumers to treatment. About two-thirds (67%) of those who received treatment through the accessible model and 23% of those who received a referral achieved a hepatitis C virus cure, meaning that the quantity of virus . . .